Anschel Technology Inc.

Anschel Technology Inc. manufactures the SightSaver™, an FDA-approved and patented device for eliciting visual evoked potentials (VEPs) during intraoperative monitoring. The device is designed to prevent post-operative visual loss (POVL)—a serious complication affecting several thousand patients annually in the United States following non-ocular surgical procedures such as spine surgery. The SightSaver™ addresses critical gaps in existing visual stimulation approaches by providing a hygienic, safe, comfortable, and reliable alternative to low-quality, non-hygienic, and unreliable legacy stimulators. The company was founded in 2011 by Dr. David Anschel, a board-certified neurologist and clinical neurophysiologist with extensive academic credentials and research background. The SightSaver products enable perioperative vision risk management through real-time intraoperative visual monitoring, supporting surgical teams in detecting and mitigating vision loss during high-risk procedures.